HOOKIPA Appoints Michael A. Kelly as Independent Director

Mr. Kelly is a former senior executive of Amgen, Inc. currently acting as Founder & President of Sentry Hill Partners, LLC., who looks back on more than two decades of executive experience in senior leadership roles in the life sciences industry. Prior to retiring from operational management he held various strategic finance and operations positions at Amgen, including the role of acting CFO of Amgen in 2010 and 2014 and positions at Biogen, Tanox and Monsanto Life Sciences. Throughout his career in pharmaceutical operations, Mr. Kelly has held a variety of strategic finance leadership roles at the Board and Committee level which have successfully led to transformation, restructuring, and integration in environments of rapid innovation and change.

Read more